Tremfya indct 200MG/2ML X2 pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F96Y1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,292
Award facts
- Contract value 100% obligated
- $15,291.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,291.85 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 13, 2026, for the supply of Tremfya Induction 200 mg/2 mL pen auto-injectors with a completion date of January 14, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. Tremfya is a biologic medication used to treat moderate to severe plaque psoriasis and other autoimmune conditions, representing a specialized pharmaceutical product critical to military healthcare delivery systems.
This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. AmerisourceBergen's extensive federal contract portfolio demonstrates its significant role as a critical vendor in the Department of Defense medical supply chain, serving military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F96Y1?
SPE2DR26F96Y1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F96Y1 worth?
The government has obligated $15,292 on SPE2DR26F96Y1.
Is contract SPE2DR26F96Y1 an order under another contract?
Yes. SPE2DR26F96Y1 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F96Y1 competed?
The extent of competition for SPE2DR26F96Y1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award